Clinical trial Recruiting at 1 site Interventional Ages 1 Hour to 3 Days

Standardized oral care using human milk for premature infants in the NICU

Official title: Frequent Standardized Oral Care Using Human Milk to Prevent Oral Dysbiosis and Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit

Run by University of Florida · NCT06000761 · Data updated 2026-11-12

This study is trying to see if giving regular oral care using human milk can help very low birth weight babies in the NICU stay healthier and avoid complications.

More Bronchopulmonary Dysplasia trials

Quick facts

Study typeInterventional
Ages1 Hour to 3 Days
SexAll
Enrollment218 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedNovember 23, 2023
Main results expectedSeptember 23, 2026
Study endsDecember 20, 2026
Registry record updatedJuly 8, 2026
Trial IDNCT06000761 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are mothers aged 18 or older with infants born at or before 30 weeks gestation and weighing 1500 grams or less.

Probably not a fit

Patients with congenital anomalies of the face, lungs, or gastrointestinal system, or those not expected to survive more than 7 days after delivery, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of frequent standardized oral care on very low birth weight (VLBW) infants in the neonatal intensive care unit (NICU). It aims to address the lack of established guidelines for oral care in this vulnerable population, which is at high risk for complications such as ventilator-associated pneumonia and bronchopulmonary dysplasia. The study will follow 168 VLBW infants for four weeks after birth to assess the effects of this intervention on their health outcomes. By developing evidence-based guidelines, the research seeks to improve the overall care and health of these infants.

Why it matters

Potential benefit: If successful, this study could lead to improved health outcomes and reduced complications for premature infants in NICUs.

How similar studies have gone: While similar approaches have shown success in critically ill adults, this specific intervention for VLBW infants is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

* Mother ≥18 years of age
* ≤ 30 weeks gestation
* Born weighing ≤ 1500 grams

Exclusion:

* Congenital anomalies of the face, lungs, or gastrointestinal system
* Not expected to live \> 7 days following delivery.

Where it's running

  • Neonatal intensive care unit at Shands children's hospital at the Univeristy of Florida
    Gainesville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Leslie Parker, PHD — University of Florida
  • Study coordinator: Leslie A Parker, PhD, APRN
  • Email: parkela@ufl.edu
  • Phone: 352-273-6384

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.